| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |